BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16793961)

  • 1. Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 protein.
    Janner M; Pandey AV; Mullis PE; Flück CE
    Eur J Endocrinol; 2006 Jul; 155(1):143-51. PubMed ID: 16793961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
    Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare CYP21A2 mutation in a congenital adrenal hyperplasia kindred displaying genotype-phenotype nonconcordance.
    Khattab A; Yuen T; Al-Malki S; Yau M; Kazmi D; Sun L; Harbison M; Haider S; Zaidi M; New MI
    Ann N Y Acad Sci; 2016 Jan; 1364(1):5-10. PubMed ID: 26291314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel 9-bp insertion detected in steroid 21-hydroxylase gene (CYP21A2): prediction of its structural and functional implications by computational methods.
    Dubey S; Idicula-Thomas S; Anwaruddin M; Saravanan C; Varma RR; Maitra A
    J Biomed Sci; 2009 Jan; 16(1):3. PubMed ID: 19272182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined homozygous 21 hydroxylase with heterozygous P450 oxidoreductase mutation in a Saudi boy presented with hypertension.
    Aljabri A; Alnaim F; Alsaleh Y
    BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32994263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel 9 bp deletion (c.1271_1279delGTGCCCGCG) in exon 10 of CYP21A2 gene causing severe congenital adrenal hyperplasia.
    Anastasovska V; Kocova M; Zdraveska N; Stojiljkovic M; Skakic A; Klaassen K; Pavlovic S
    Endocrine; 2021 Jul; 73(1):196-202. PubMed ID: 33715135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and structural analysis of four novel mutations of CYP21A2 gene in Italian patients with 21-hydroxylase deficiency.
    Massimi A; Malaponti M; Federici L; Vinciguerra D; Manca Bitti ML; Vottero A; Ghizzoni L; Maccarrone M; Cappa M; Bernardini S; Porzio O
    Horm Metab Res; 2014 Jun; 46(7):515-20. PubMed ID: 24799024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare CYP 21 mutation (p.E431K) induced deactivation of CYP 21A2 and resulted in congenital adrenal hyperplasia.
    Kawashima Y; Usui T; Fujimoto M; Miyahara N; Nishimura R; Hanaki K; Kanzaki S
    Endocr J; 2015; 62(1):101-6. PubMed ID: 25319875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and structural consequences of a novel point mutation in the CYP21A2 gene causing congenital adrenal hyperplasia: potential relevance of helix C for P450 oxidoreductase-21-hydroxylase interaction.
    Riepe FG; Hiort O; Grötzinger J; Sippell WG; Krone N; Holterhus PM
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2891-5. PubMed ID: 18445671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of missense mutations and deletions on membrane anchoring and enzyme function of human steroid 21-hydroxylase (P450c21).
    Lajic S; Nikoshkov A; Holst M; Wedell A
    Biochem Biophys Res Commun; 1999 Apr; 257(2):384-90. PubMed ID: 10198222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency.
    L'Allemand D; Tardy V; Grüters A; Schnabel D; Krude H; Morel Y
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4562-7. PubMed ID: 11134109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular model of human CYP21 based on mammalian CYP2C5: structural features correlate with clinical severity of mutations causing congenital adrenal hyperplasia.
    Robins T; Carlsson J; Sunnerhagen M; Wedell A; Persson B
    Mol Endocrinol; 2006 Nov; 20(11):2946-64. PubMed ID: 16788163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3D model of human P450c21: study of the putative effects of steroid 21-hydroxylase gene mutations.
    Mornet E; Gibrat JF
    Hum Genet; 2000 Mar; 106(3):330-9. PubMed ID: 10798363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency.
    Menassa R; Tardy V; Despert F; Bouvattier-Morel C; Brossier JP; Cartigny M; Morel Y
    J Clin Endocrinol Metab; 2008 May; 93(5):1901-8. PubMed ID: 18319307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of molecular genetics on congenital adrenal hyperplasia management.
    Balsamo A; Baldazzi L; Menabò S; Cicognani A
    Sex Dev; 2010 Sep; 4(4-5):233-48. PubMed ID: 20639616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterisation of the H365Y mutation of the 21-hydroxylase gene in congenital adrenal hyperplasia.
    Gaffney D; Howie AF; Bakkush AM; Hoffmann TM; Mason JI; Wallace AM; Donaldson MD
    J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):109-14. PubMed ID: 21134444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of two novel point mutations in the CYP21 gene causing simple virilizing forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Krone N; Riepe FG; Grötzinger J; Partsch CJ; Sippell WG
    J Clin Endocrinol Metab; 2005 Jan; 90(1):445-54. PubMed ID: 15483094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four novel missense mutations in the CYP21A2 gene detected in Russian patients suffering from the classical form of congenital adrenal hyperplasia: identification, functional characterization, and structural analysis.
    Grischuk Y; Rubtsov P; Riepe FG; Grötzinger J; Beljelarskaia S; Prassolov V; Kalintchenko N; Semitcheva T; Peterkova V; Tiulpakov A; Sippell WG; Krone N
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4976-80. PubMed ID: 16984992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital adrenal hyperplasia: the molecular basis of 21-hydroxylase deficiency in H-2(aw18) mice.
    Riepe FG; Tatzel S; Sippell WG; Pleiss J; Krone N
    Endocrinology; 2005 Jun; 146(6):2563-74. PubMed ID: 15731361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of human 21-hydroxylase (P450c21) in bacterial and mammalian cells: a system to characterize normal and mutant enzymes.
    Hu MC; Chung BC
    Mol Endocrinol; 1990 Jun; 4(6):893-8. PubMed ID: 2233746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.